PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Exco InTouch Partners with MMG to Provide Effective Patient Recruitment and Retention - Exco InTouch partners with MMG to provide effective patient recruitment and retention in clinical trials
Exco InTouch Partners with MMG to Provide Effective Patient Recruitment and Retention

 

NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2008/09/09 - Exco InTouch partners with MMG to provide effective patient recruitment and retention in clinical trials.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Exco InTouch the leading mobile messaging provider for the pharmaceutical industry, announces that it has partnered with US-headquartered MMG an international industry leader in patient enrolment for clinical trials to enhance the efficacy of patient recruitment and retention services for pharmaceutical sponsors. The integration of Exco InTouch's REACT short messaging service
(SMS) technology will complement MMG's services, enhancing the company's ability to quickly find good quality patients through advertising, pre-screening and selection. Additionally, Exco InTouch's innovative mobile technology allows MMG to interact directly with subjects during a clinical study, which can significantly improve retention for faster and more cost-effective trials.

REACT SMS technology from Exco InTouch will be offered by MMG in synergy with its existing enrolment services, enabling sponsors to quickly identify and pre-screen potential subjects for clinical studies. The partnership between Exco InTouch and MMG comes as a response to the demand from pharmaceutical sponsors for new and innovative methods to find good quality, compliant volunteers for clinical trials. Exco InTouch's technology complements MMG's existing patient communication and recruitment services, offering SMS-based recruitment advertising and enabling fast assessment of potential subjects' suitability via SMS.

In addition to substantially improving patient recruitment, the new combined services will offer significant benefits to sponsors throughout the life of the trial. REACT produces and updates patient visit schedules, meaning that site personnel do not need to refer to the trial protocol each time a change is made. Customized visit and medication reminders are automatically sent to patients via SMS, ensuring that subjects comply with the trial requirements while minimizing the input required from study organizers.

John Benbrook, CEO of MMG, comments: "Pharmaceutical sponsors are constantly looking for novel ways to improve patient selection for clinical trials as well as retaining subjects throughout the study. Adding Exco InTouch's innovative SMS communication technology to our existing patient recruitment and retention services enhances our ability to find good quality patients and to support participants throughout the trial to ensure retention."

"The new combined services from Exco InTouch and MMG reflect our close collaboration, enabling sponsors to streamline clinical trials and offering significant productivity gains. In addition, SMS communication between sponsors and patients ensures that subjects feel supported throughout the trial, typically improving retention by 20%," adds Tim Davis, Co-Founder of Exco InTouch.

The use of SMS technology as part of complete patient recruitment and retention strategies will be the subject of a joint presentation by Exco InTouch and MMG at the 4th Annual Patient Recruitment and Retention in Clinical Trials, 13-15 October, 2008, Amsterdam, Holland. Exco InTouch and MMG will co-host the half day pre-conference workshop focusing on patient recruitment and retention strategies.

For further information on the Exco InTouch portfolio of solutions, please call +44 1279 408 210 or +1 949 725 2946.

For further information on MMG please call +44 (0) 1279 461708 or +1 (301)
984-7191.

For further press information please contact: Eleanor CallanMonk, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA T: +44 1477 539539 F: +44 1477 539540 E: exco[.]scottpr.com

About Exco InTouch
Exco InTouch provides secure mobile communication for healthcare and biopharmaceutical applications improving subject recruitment, retention and compliance during clinical trials and pharmaceutical marketing studies.

About MMG
MMG, a Ketchum company and part of the Omnicom Group (NYSE:OMC) family, is the premier global patient recruitment and retention agency. With experience across a vast range of therapeutic areas, populations and study types in over 70 countries, MMG provides strategies which will be accepted by study teams, ethics committees and patient populations whilst delivering the best return on investment for the sponsor.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Exco InTouch Partners with MMG to Provide Effective Patient Recruitment and Retention

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Eleanor CallanMonk 
+44 1279 408 210 info[.]excointouch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)